|
Prevalence of various components of the metabolic syndrome among the 9795 randomized participants in the FIELD study |
||||||
| Men (n = 6138) |
Women (n = 3657) |
Total (n = 9795) |
||||
| Metabolic syndrome feature: ATPIII criteria * |
n |
% |
n |
% |
n |
% |
|
|
||||||
| Waist measurement (women >88 cm; men >102 cm) |
3613 |
58.9 |
3034 |
83.0 |
6647 |
67.9 |
| Triglycerides >= 1.7 mmol/L |
3073 |
50.1 |
2020 |
55.2 |
5093 |
52.0 |
| HDL (men <40 mg/dL; women <50 mg/dL) |
3365 |
54.8 |
2455 |
67.1 |
5820 |
59.4 |
| Hypertension (SBP >= 130 and DBP >= 85 mm Hg) |
5050 |
82.3 |
3131 |
85.6 |
8181 |
83.5 |
| Fasting glucose >= 110 mg/dL or diabetes |
6133 |
99.9 |
3646 |
99.7 |
9779 |
99.8 |
|
* When 3 of the 5 listed characteristics are present, a diagnosis of metabolic syndrome is established (84% of the cohort met the criteria) | ||||||
The FIELD Study Investigators Cardiovascular Diabetology 2005 4:13 doi:10.1186/1475-2840-4-13 |
||||||